Clinical Rheumatology

, Volume 26, Issue 7, pp 1192–1194

Cocaine use and its rheumatic manifestations: a case report and discussion

Case Report

Abstract

Cocaine use can be associated with a wide spectrum of rheumatic manifestations. It poses a diagnostic challenge as the patients usually withhold the information of cocaine use, and no serological tests are available to establish this diagnosis. We report a patient with vasculopathic syndrome secondary to cocaine use. Despite initial denial of drug abuse, skin biopsy suggested the diagnosis, which was subsequently confirmed by urine drug testing. Differentiating cocaine-associated pseudovasculitis from true vasculitis is necessary, as conventional treatment is usually ineffective without complete abstinence from cocaine use and may be associated with significant morbidity as well as mortality.

Keywords

ANCA Cocaine use Pseudovasculitis 

References

  1. 1.
    Cregler L, Mark H (1986) Medical complications of cocaine abuse. N Engl J Med 315(3):1495–1500 (December)PubMedCrossRefGoogle Scholar
  2. 2.
    Friedman DR, Wolfsthal SD (2005) Cocaine-induced pseudovasculitis. Mayo Clin Proc 80(5):671–673 (May)PubMedCrossRefGoogle Scholar
  3. 3.
    Rowshani AT, Schot LJ, Berge IJ (2004) c-ANCA as a serological pitfall. Lancet 363:782 (March)PubMedCrossRefGoogle Scholar
  4. 4.
    Gertner E, Hamlar D (2002) Necrotizing granulomatous vasculitis associated with cocaine use. J Rheumatol 29:1795–1797PubMedGoogle Scholar
  5. 5.
    Orriols R, Munoz X, Ferrer J et al (1996) Cocaine-induced Churg–Strauss vasculitis. Eur Respir J 9:175–177PubMedCrossRefGoogle Scholar
  6. 6.
    Chevalier X, Rostoker G, Larget-Piet B et al (1995) Schoenlein–Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 43(5):348–349PubMedGoogle Scholar
  7. 7.
    Hofbauer G, Hafner J, Trueb RM (1999) Urticarial vasculitis following cocaine use. Br J Dermatol 141:600–601PubMedCrossRefGoogle Scholar
  8. 8.
    Trozak DJ, Gould WM (1984) Cocaine abuse and connective tissue disease. J Am Acad Dermatol 10(3):525 (March)PubMedGoogle Scholar
  9. 9.
    Balbir-Gurman A, Braun-Moscovici Y, Nahir AM (2001) Cocaine-induced Raynaud’s phenomenon and ischaemic finger necrosis. Clin Rheumatol 20:376–378PubMedCrossRefGoogle Scholar
  10. 10.
    Zamorea-Quezada JC, Dinerman H, Stadecker MJ et al (1988) Muscle and skin infarction after free-basing cocaine (crack). Ann Intern Med 108(4):564–565 (April)Google Scholar
  11. 11.
    Tomecki KJ, Wikas SM (1985) Cocaine-related bullous disease. J Am Acad Dermatol 12(3):585–586 (March)PubMedCrossRefGoogle Scholar
  12. 12.
    Hofbauer G, Burg G, Nestle FO (2000) Cocaine-related Stevens–Johnson syndrome. Dermatology 201:258–260PubMedCrossRefGoogle Scholar
  13. 13.
    Weisner O, Russell KA, Lee AS et al (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50(9):2954–2965 (September)CrossRefGoogle Scholar
  14. 14.
    Trimarchi M, Gregorini G, Facchetti F et al (2001) Cocaine induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine (Baltimore) 80:391–404CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of MedicineUniversity of Mississippi Medical CenterJacksonUSA

Personalised recommendations